Martin E. Cooper
Respiratory, Inflammation And Autoimmunity Innovative Medicines, AstraZeneca R&D
Moelndal, O, Sweden
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Spirocyclopentane as a Novel Scaffold for Potent Ghrelin Receptor Full Agonists.
Journal: Journal of medicinal chemistry
Published: December 05, 2025
Is Hepatic Cannabinoid 1 Receptor a Key Driver of Obesity? Implications of the Weight-Reducing Efficacy of the Hepatotropic Inverse Agonist TM38837.
Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity
Published: November 07, 2024
Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837.
Journal: Bioorganic & medicinal chemistry letters
Published: August 21, 2023
Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837.
Journal: British journal of pharmacology
Published: August 15, 2023
Correction: Evaluation of a Mobile App to Enhance Relational Awareness and Change During Cognitive Analytic Therapy: Mixed Methods Case Series.
Journal: JMIR mental health
Published: January 13, 2021
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists.
Journal: Journal of medicinal chemistry
Published: August 14, 2020
Blending Cognitive Analytic Therapy With a Digital Support Tool: Mixed Methods Study Involving a User-Centered Design of a Prototype App.
Journal: JMIR mental health
Published: May 14, 2020
Evaluation of a Mobile App to Enhance Relational Awareness and Change During Cognitive Analytic Therapy: Mixed Methods Case Series.
Journal: JMIR mental health
Published: May 13, 2020
A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
Journal: PloS one
Published: April 13, 2016
Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists.
Journal: Bioorganic & medicinal chemistry letters
Published: November 01, 2013
Design, synthesis and structure activity relationships of spirocyclic compounds as potent CCR1 antagonists.
Journal: Bioorganic & medicinal chemistry letters
Published: March 14, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026